Form 4 for INDP Indaptus Therapeutics, Inc.
Accepted 2022-09-08 00:00:00 ET · period of report 2022-09-06 · accession 0001493152-22-025319 · SEC index · Original document
Summary rows
Aggregated the way they appear in lists: one row per insider, transaction code and security table.
| X | Filed | Traded | Ticker | Insider | Title | Type | Price | Qty | Owned | ΔOwn | Value |
|---|---|---|---|---|---|---|---|---|---|---|---|
| M | 2022-09-08 | 2022-09-06+ | INDP | Meckler Jeffrey A | CEO, Dir | P - Purchase | $2.56 | +9,692 | 55.1K | +21% | +$24.8K |
Purchase Sale Sale after option exercise All abbreviations
Every reported transaction
| # | Table | Security | Date | Code | A/D | Shares | Price | Owned after | Own | Exercise / expiry | Underlying | Footnotes |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 1 | Common | Common stock | 2022-09-06 | P | A | 1,060 | $2.44 | 46,434 | D | — | — | |
| 2 | Common | Common stock | 2022-09-07 | P | A | 8,632 | $2.57 | 55,066 | D | — | — |